ArticleBriefings in bioinformatics2024
Integrating genetic algorithms and language models for enhanced enzyme design.
Article in Briefings in bioinformatics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- How far can you go? Extrapolating values of catalytic activity from known protein landscapes in natural and directed evolution.Chemical Society reviews · 2026Review
- FGeneBERT: function-driven pre-trained gene language model for metagenomics.Briefings in bioinformatics · 2025Article
- FGeneBERT: function-driven pre-trained gene language model for metagenomics.Briefings in bioinformatics · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Enzymes are molecular machines optimized by nature to allow otherwise impossible chemical processes to occur. Their design is a challenging task due to the complexity of the protein space and the intricate relationships between sequence, structure, and function. Recently, large language models (LLMs) have emerged as powerful tools for modeling and analyzing biological sequences, but their application to protein design is limited by the high cardinality of the protein space. This study introduces a framework that combines LLMs with genetic algorithms (GAs) to optimize enzymes. LLMs are trained on a large dataset of protein sequences to learn relationships between amino acid residues linked to structure and function. This knowledge is then leveraged by GAs to efficiently search for sequences with improved catalytic performance. We focused on two optimization tasks: improving the feasibility of biochemical reactions and increasing their turnover rate. Systematic evaluations on 105 biocatalytic reactions demonstrated that the LLM-GA framework generated mutants outperforming the wild-type enzymes in terms of feasibility in 90% of the instances. Further in-depth evaluation of seven reactions reveals the power of this methodology to make "the best of both worlds" and create mutants with structural features and flexibility comparable with the wild types. Our approach advances the state-of-the-art computational design of biocatalysts, ultimately opening opportunities for more sustainable chemical processes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.